Handa Pharmaceuticals, Inc. 6620.TWO Stock
Handa Pharmaceuticals, Inc. Price Chart
Handa Pharmaceuticals, Inc. 6620.TWO Financial and Trading Overview
| Handa Pharmaceuticals, Inc. stock price | 158 TWD |
| Previous Close | 166.5 TWD |
| Open | 166 TWD |
| Bid | 163 TWD x 0 |
| Ask | 165 TWD x 0 |
| Day's Range | 164 - 168 TWD |
| 52 Week Range | 46 - 221 TWD |
| Volume | 213.27K TWD |
| Avg. Volume | 604.41K TWD |
| Market Cap | 21.85B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 5.39 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6620.TWO Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 54.88822 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Handa Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 230.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 221 TWD |
| 52 Week Low | 46 TWD |
| 50-Day Moving Average | 167.34 TWD |
| 200-Day Moving Average | 119.4 TWD |
6620.TWO Share Statistics
| Avg. Volume (3 month) | 604.41K TWD |
| Avg. Daily Volume (10-Days) | 436.03K TWD |
| Shares Outstanding | 132.8M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 178.97M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 2.997 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Handa Pharmaceuticals, Inc.
| Country | Taiwan |
| State | N/A |
| City | Tainan City |
| Address | No.23, Nanke 3rd Road |
| ZIP | 74147 |
| Phone | 886 6 505 7508 |
| Website | https://www.handapharma.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. It develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; HND-033 and HND-027, an oncology products; and Quetiapine XR for the treatment of schizophrenia. The company also develops HND-002 for the treatment of heartburn; HND-004, a diabetic drug; HND-032; and HND-026, a GI drug. Handa Pharmaceuticals, Inc. was founded in 2014 and is headquartered in Tainan City, Taiwan.
Q&A For Handa Pharmaceuticals, Inc. Stock
What is a current 6620.TWO stock price?
Handa Pharmaceuticals, Inc. 6620.TWO stock price today per share is 158 TWD.
How to purchase Handa Pharmaceuticals, Inc. stock?
You can buy 6620.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Handa Pharmaceuticals, Inc.?
The stock symbol or ticker of Handa Pharmaceuticals, Inc. is 6620.TWO.
Which industry does the Handa Pharmaceuticals, Inc. company belong to?
The Handa Pharmaceuticals, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Handa Pharmaceuticals, Inc. have in circulation?
The max supply of Handa Pharmaceuticals, Inc. shares is 141.09M.
What is Handa Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Handa Pharmaceuticals, Inc. PE Ratio is 29.31354500 now.
What was Handa Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Handa Pharmaceuticals, Inc. EPS is 5.39 TWD over the trailing 12 months.
Which sector does the Handa Pharmaceuticals, Inc. company belong to?
The Handa Pharmaceuticals, Inc. sector is Healthcare.